Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:42 PM
Ignite Modification Date:
2025-12-24 @ 10:42 PM
NCT ID:
NCT00890435
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Patients or their parents/guardians (if patient is a minor) consented to participate in a phase I treatment clinical trial with an optional pharmacokinetic (PK) component, within the past 4 weeks
* Must not have withdrawn consent for the phase I treatment study
* Patients or their parents/guardians are eligible regardless of whether they initially agreed to participate in the PK sampling
* Must not withdraw consent for PK sampling prior to completing the study questionnaire if initially agreed to optional PK sampling
* Patients or their parents/guardians are eligible regardless of whether they actually completed PK sampling (provided reasons for not completing the sampling was not withdrawal of the initial consent to the phase I treatment study)
PATIENT CHARACTERISTICS:
* Not cognitively or physically impaired
* May participate no more than once in the study questionnaire survey
PRIOR CONCURRENT THERAPY:
* No limit on participation in the number of prior phase I trials or other studies
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00890435
Study Brief:
Protocol Section:
NCT00890435